CAS: 85933-19-3
Carbidopa Related Compound A (3-O-Methylcarbidopa)
CAS:85933-19-3
Aromatic organic derivatives of hydrazine or of hydroxylamine
Formula:
C11H16N2O4
Color and Shape:
Yellow Tan Powder
Molecular weight:
240.11101
Estimated delivery in United States, on Monday 30 Dec 2024
rac-Carbidopa EP Impurity C Trifluoroacetate (Carbidopa USP Related Compound A Trifluoroacetate)
CAS:85933-19-3
Formula:
C11H16N2O4·C2HF3O2
Color and Shape:
White To Off-White Solid
Molecular weight:
240.26 114.02
Ref: 4Z-C-2124
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS:85933-19-3
Formula:
C11H16N2O4
Molecular weight:
240.26
Ref: 4Z-C-2125
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
Controlled ProductCAS:85933-19-3
Formula:
C11H16N2O4
Color and Shape:
Neat
Molecular weight:
240.26
Ref: 86-MM1501.09
| 25mg | 862.00 € | ||
| 100mg | 1,355.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
3-O-Methyl Carbidopa
CAS:85933-19-3
Applications 3-O-Methylcarbidopa is an impurity of Carbidopa (C175915) with potential use as therapeutic agents to …
Formula:
C11H16N2O4
Color and Shape:
Neat
Molecular weight:
240.26
Ref: TR-M294590
| 25mg | 773.00 € | ||
| 50mg | 1,441.00 € | ||
| 100mg | 2,377.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
3-O-Methyl carbidopa
Controlled ProductCAS:85933-19-3
3-O-Methyl carbidopa is a metabolite of L-3,4-dihydroxyphenylalanine that is used as a drug in the …
Formula:
C11H16N2O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
240.26 g/mol
Ref: 3D-FM25477
| 1mg | 248.00 € | ||
| 2mg | 364.00 € | ||
| 5mg | 517.00 € | ||
| 10mg | 740.00 € | ||
| 25mg | 1,160.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
